Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation

Clinical trial NCT01186250 · COMPLETED

Trial details

NCT number: NCT01186250
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cardiac Allograft Vasculopathy

Start date: 2010-07-01
Primary completion: 2013-08-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.